These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15272245)

  • 1. Prophylaxis of autoimmune diabetes by antigen based immune modulation: are we there yet?
    Bot A; von Herrath M
    Minerva Med; 2004 Apr; 95(2):105-14. PubMed ID: 15272245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of multimer technologies in type 1 diabetes prediction strategies.
    Fierabracci A
    Diabetes Metab Res Rev; 2011 Mar; 27(3):216-29. PubMed ID: 21309048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?
    Roep BO
    Springer Semin Immunopathol; 2002 Dec; 24(3):261-71. PubMed ID: 12503054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic "vaccination" for the prevention of autoimmune diabetes (type 1A).
    Simone EA; Wegmann DR; Eisenbarth GS
    Diabetes Care; 1999 Mar; 22 Suppl 2():B7-15. PubMed ID: 10097893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
    Sobel DO; Creswell K
    Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved T cell assay for identification of type 1 diabetes patients.
    Brooks-Worrell B; Warsen A; Palmer JP
    J Immunol Methods; 2009 May; 344(1):79-83. PubMed ID: 19328805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Chen YG
    Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic strategies to halt or prevent type 1 diabetes.
    Cooke A; Phillips JM; Parish NM
    Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
    Marée AF; Santamaria P; Edelstein-Keshet L
    Int Immunol; 2006 Jul; 18(7):1067-77. PubMed ID: 16728432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
    Aly TA; Ide A; Humphrey K; Barker JM; Steck A; Erlich HA; Yu L; Miao D; Redondo MJ; McFann K; Roberts CM; Babu SR; Norris JM; Eisenbarth GS; Rewers MJ
    J Autoimmun; 2005; 25 Suppl():40-5. PubMed ID: 16242305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
    Silveira PA; Grey ST
    Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.
    Kent SC; Chen Y; Bregoli L; Clemmings SM; Kenyon NS; Ricordi C; Hering BJ; Hafler DA
    Nature; 2005 May; 435(7039):224-8. PubMed ID: 15889096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
    Waid DM; Wagner RJ; Putnam A; Vaitaitis GM; Pennock ND; Calverley DC; Gottlieb P; Wagner DH
    Clin Immunol; 2007 Aug; 124(2):138-48. PubMed ID: 17560173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.